
Lung Cancer
Latest News
Latest Videos

CME Content
More News

Star Scientific, a Virginia-based company, has petitioned the FDA to approve the sale of what it claims is a

Hospitals, pharmacists, and physicians across the United States are reporting shortages of critical anticancer drugs, including carboplatin, cisplatin, dacarbazine, fludarabine, and cytarabine.

This year in the US, the American Cancer Society estimates that lung cancer will kill more people than breast, prostate, colon, liver, and kidney cancers combined, making it the leading cause of cancer death among Americans.

The results of Amgen's %u201C145 study%u201D of Aranesp in patient's with late-stage small-cell lung cancer (SCLC) are released.

Chemotherapy is widely used in the treatment of malignant mesothelioma, but it has never been compared in a randomized trial with active symptom control (ASC) alone.

Lung cancer is the second most common cancer and the most common cause of cancer-related death in both men and women in the US. At the12th World Conference on Lung Cancer (WCLC), the world%u2019s top lung cancer specialists convened to present and discuss the latest research in this disease. Key themes included accurate targets, new combinations of drugs to reduce toxicity, and strategies to improve outcomes.

Oncology & Biotech News provides updates from major oncology meetings because symposia remain an important means for disseminating new data. This issue, we highlight two important meetings: 2007 Breast Cancer Symposium (in San Francisco) and the World Conference on Lung Cancer (in Korea).

A common treatment option for prostate cancer is radiation therapy, which is as effective in treating the disease as surgical removal of the prostate.

Highlights from the 50th Annual Meeting of the American Society of Hematology.

A pivotal phase III study is currently underway to evaluate the efficacy and safety of Novartis’ novel anti-cancer compound ASA404 in patients with non–small cell lung cancer (NSCLC).

Lately, ultrasound has been used to increase sampling accuracy. Trans-thoracic ultrasound does not provide adequate guidance because of the difficulty in imaging the mediastinum








































